Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Clinical trial NCT05277766 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05277766
Sponsor: University Hospital, Ghent
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Peritoneal Carcinomatosis Peritoneal Metastases Colorectal Cancer Small Bowel Cancer Appendix Cancer Gastric Cancer Pancreatic Cancer Bile Duct Cancer

Start date: 2022-11-21
Primary completion: 2026-08-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.